Literature DB >> 35316284

Evaluating the population-level effects of overdose prevention sites and supervised consumption sites in British Columbia, Canada: Controlled interrupted time series.

Dimitra Panagiotoglou1.   

Abstract

BACKGROUND: On 14 April 2016, British Columbia's Provincial Medical Health Officer declared the overdose crisis a public health emergency, sanctioning the implementation of new overdose prevention sites (OPS) and supervised consumption sites (SCS) across the province.
METHODS: We used the BC Centre for Disease Control's Provincial Overdose Cohort of all overdose events between 1 January 2015 and 31 December 2017 to evaluate the population-level effects of OPSs and SCSs on acute health service use and mortality. We matched local health areas (LHA) that implemented any site with propensity score matched controls and conducted controlled interrupted time series analysis.
RESULTS: During the study period, twenty-five OPSs and SCSs opened across fourteen of British Columbia's 89 LHAs. Results from analysis of LHAs with matched controls (i.e. excluding Vancouver DTES) were mixed. Significant declines in reported overdose events, paramedic attendance, and emergency department visits were observed. However, there were no changes to trends in monthly hospitalization or mortality rates. Extensive sensitivity analyses found these results persisted.
CONCLUSIONS: We found OPSs and SCSs reduce opioid-related paramedic attendance and emergency department visit rates but no evidence that they reduce local hospitalization or mortality rates.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35316284      PMCID: PMC8939833          DOI: 10.1371/journal.pone.0265665

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  33 in total

1.  Mobile safe injecting facilities in Barcelona and Berlin.

Authors:  Paul Dietze; Rebecca Winter; Alisa Pedrana; Astrid Leicht; Xavier Majó I Roca; M Teresa Brugal
Journal:  Int J Drug Policy       Date:  2012-03-30

Review 2.  The multiple baseline design for evaluating population-based research.

Authors:  Nathan G Hawkins; Robert W Sanson-Fisher; Anthony Shakeshaft; Catherine D'Este; Lawrence W Green
Journal:  Am J Prev Med       Date:  2007-08       Impact factor: 5.043

3.  Public opinion towards supervised injection facilities and heroin-assisted treatment in Ontario, Canada.

Authors:  Michelle Firestone Cruz; Jayadeep Patra; Benedikt Fischer; Jürgen Rehm; Kate Kalousek
Journal:  Int J Drug Policy       Date:  2007-01-12

4.  Testing for serial correlation in least squares regression. II.

Authors:  J DURBIN; G S WATSON
Journal:  Biometrika       Date:  1951-06       Impact factor: 2.445

Review 5.  Supervised injection services: what has been demonstrated? A systematic literature review.

Authors:  Chloé Potier; Vincent Laprévote; Françoise Dubois-Arber; Olivier Cottencin; Benjamin Rolland
Journal:  Drug Alcohol Depend       Date:  2014-10-23       Impact factor: 4.492

6.  Modelling the combined impact of interventions in averting deaths during a synthetic-opioid overdose epidemic.

Authors:  Michael A Irvine; Margot Kuo; Jane A Buxton; Robert Balshaw; Michael Otterstatter; Laura Macdougall; M-J Milloy; Aamir Bharmal; Bonnie Henry; Mark Tyndall; Daniel Coombs; Mark Gilbert
Journal:  Addiction       Date:  2019-06-28       Impact factor: 6.526

7.  New Data on Opioid Use and Prescribing in the United States.

Authors:  Anne Schuchat; Debra Houry; Gery P Guy
Journal:  JAMA       Date:  2017-08-01       Impact factor: 56.272

Review 8.  Patient Characteristics and Outcomes in Unintentional, Non-fatal Prescription Opioid Overdoses: A Systematic Review.

Authors:  Mark J Elzey; Sarah M Barden; Eric S Edwards
Journal:  Pain Physician       Date:  2016-05       Impact factor: 4.965

9.  Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies.

Authors:  Peter C Austin
Journal:  Pharm Stat       Date:  2011 Mar-Apr       Impact factor: 1.894

Review 10.  Opioid-induced respiratory depression: reversal by non-opioid drugs.

Authors:  Rutger van der Schier; Margot Roozekrans; Monique van Velzen; Albert Dahan; Marieke Niesters
Journal:  F1000Prime Rep       Date:  2014-09-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.